WFIKKN2 is secreted and elevated in blood plasma of HER2-positive breast cancer patients – implications in cancer surveillance and recurrence monitoring
Abstract Current methods for post-treatment cancer surveillance and recurrence monitoring rely mainly on biophysical imaging methods like CT and MRI. Limitations associated with these approaches include risk of radiation, high cost and sophistication in operation. Minimally invasive blood test is a...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-11-01
|
| Col·lecció: | Biomarker Research |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s40364-025-00853-4 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|